A new piece to the puzzle sheds light on how UHRF1 regulates gene activity

Scientists have discovered new details about the UHRF1 protein. UHRF1 catalyses particular steps that are required for marking DNA with epigenetic modifications that suppress parts of the genome. The molecule may serve as a target for drug therapies because it is produced at elevated levels in cancer cells. (Mehr in: Cancer News — ScienceDaily)